Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.
Fragoulakis V, Swen JJ, Koufaki MI, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VHM, Dupui M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Manson LEN, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, van der Wouden CH, Dávila-Fajardo CL, Dolžan V, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ, Patrinos GP, Mitropoulou C.
Fragoulakis V, et al. Among authors: rial sebbag e.
EClinicalMedicine. 2025 Dec 16;91:103686. doi: 10.1016/j.eclinm.2025.103686. eCollection 2026 Jan.
EClinicalMedicine. 2025.
PMID: 41502919
Free PMC article.